%0 Journal Article
%A Guo, Lanwei
%A Wang, Le
%A Cai, Lin
%A Zhang, Yuelun
%A Feng, Xiaoshuang
%A Zhu, Chenxin
%A Gao, Wendong
%A Cardoso, Rafael
%A Yang, Haiyan
%A Dai, Min
%A Brenner, Hermann
%A Chen, Hongda
%T Global Distribution of Colorectal Cancer Staging at Diagnosis: An Evidence Synthesis.
%J Clinical gastroenterology and hepatology
%V nn
%@ 1542-3565
%C New York, NY
%I Elsevier Science
%M DKFZ-2024-02736
%P nn
%D 2024
%Z epub
%X Stage at diagnosis is a key prognostic factor for colorectal cancer (CRC) survival. We aimed to assess the global distribution of CRC staging at diagnosis using population-based or hospital-based registry data.We systematically searched in MEDLINE and Embase from their inception until 6 December 2023. Grey literature was searched through published cancer reports. Studies from population-based or hospital-based cancer registries reporting the stage distribution of diagnosed CRC were included. We extracted stage-specific proportions among patients with CRC based on TNM, SEER, or Dukes staging systems. Subgroup analyses by sex, age, tumor site, calendar period, and status of population-based screening were performed. Correlations between the Human Development Index (HDI), Socio-Demographic Index (SDI), and the distant metastatic CRC proportion were also evaluated.84 eligible studies/reports from 46 countries were analyzed, covering 3.8 million patients. Among 36 countries included in the main analysis, the most recent distant metastatic CRC proportions varied from 16.2
%K colorectal cancer (Other)
%K stage (Other)
%K systematic review (Other)
%F PUB:(DE-HGF)16
%9 Journal Article
%$ pmid:39694204
%R 10.1016/j.cgh.2024.11.019
%U https://inrepo02.dkfz.de/record/295923